A rare but life-threatening immune reaction in response to lamotrigine (Lamictal) requires prompt diagnosis and treatment, according to a recent alert from the U.S. Food and Drug Administration (FDA). On April 25, the FDA issued what it calls a “drug safety communication” about the risk of a condition so rare that few neurologists have […]
The US Food and Drug Administration (FDA) granted premarket approval for Medtronic’s Deep Brain Stimulation DBS) therapy as adjunctive treatment for reducing the frequency of partial-onset seizures in individuals 18 years of age or older who are refractory to 3 or more antiepileptic medications. The therapy delivers controls electrical pulses to the anterior nucleus […]
LivaNova Commences Clinical Study to Evaluate Treatment Outcomes for Novel Microburst VNS Therapy System
LivaNova today announced the launch and enrollment of the first patient in a clinical study to examine the use of LivaNova’s new Microburst Vagus Nerve Stimulation Therapy® (“VNS Therapy”) System. This feasibility study will determine the initial safety and effectiveness of delivering VNS Therapy using high frequency bursts of stimulation (“Microburst”) in patients who have […]
Exposure to sodium valproate or a combination of antiepileptic drugs (AEDs) in utero is associated with worse attainment on national educational tests for 7-year-olds, according to a study published online March 26 in the Journal of Neurology, Neurosurgery & Psychiatry. Arron S. Lacey, from Swansea University Medical School in the United Kingdom, and colleagues identified […]
Kaduna State University (KASU) Professor of Pharmacology and Toxicology, Ben Chindo, has discovered herbal cure for epilepsy, and a kind of mental disorder known as schizophrenia. The KASU Don, who is also the dean of KASU’s School of Pharmaceutical Studies, announced the breakthrough at the university’s 2nd Professorial Inaugural Lecture on Friday.
Brain training devised by a Brighton clinical researcher can cut the number and frequency of epileptic seizures in patients who have not responded to drug treatment. Details of the groundbreaking research have been published in The Lancet and Cell Press journal Ebiomedicine. One in 100 people suffer with epilepsy – 50 million people […]